Objective.-To review tenets of basic quality assurance and identify opportu
nities for quality improvement in the laboratory assessment of prognostic f
actors.
Design.-College of American Pathologists Q-Probes data obtained from hundre
ds of American laboratories throughout the 1990s are used to illustrate lab
oratory performance and practice opportunities in the preanalytic, analytic
, and postanalytic phases of the total testing process.
Results.-A wide range of performance deficiencies are documented, most in t
he preanalytic and postanalytic phases, and contributed by individuals outs
ide and not under the control of the laboratory. In the analytic phase, the
effectiveness of checklists on the content and completeness of reported di
agnostic and prognostic data for breast and colon cancers is proven,
Conclusions.-In the preanalytic phase, marked enhancements in quality would
result from improvements in (1) patient and specimen identification, (2) a
dherence to patient-sampling and specimen-handling requirements, and (3) co
mmunication to the laboratory of the pertinent clinical context of the indi
vidual test. Once basic analytic quality control and laboratory quality ass
urance issues are resolved, a focus on standardization and enhancement of p
reanalytic and postanalytic communications and satisfaction of clinical exp
ectations becomes the source of improved laboratory performance.